| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mehrdad Mohammadi, Mohammad Shayestehpour, Hamed Mirzae. The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. vol 25. issue 4. 2021-10-04. PMID:34428473. |
however, the major concern is the efficacy of subunit vaccines and elicited antibodies to neutralize the variants of sars-cov-2 like b.1.1.7 (alpha), b.1.351 (beta) and p1 (gamma), b.1.617 (delta) and c.37 (lambda). |
2021-10-04 |
2023-08-13 |
human |
| Mehrdad Mohammadi, Mohammad Shayestehpour, Hamed Mirzae. The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. vol 25. issue 4. 2021-10-04. PMID:34428473. |
to date, a low or no significant impact on vaccine efficacy against alpha and delta variants has been reported. |
2021-10-04 |
2023-08-13 |
human |
| Mehrdad Mohammadi, Mohammad Shayestehpour, Hamed Mirzae. The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. vol 25. issue 4. 2021-10-04. PMID:34428473. |
such an impact on vaccine efficacy for beta, delta, gamma, and lambda variants may be even greater compared to the alpha variant. |
2021-10-04 |
2023-08-13 |
human |
| N I Borisova, I A Kotov, A A Kolesnikov, V V Kaptelova, A S Speranskaya, L Yu Kondrasheva, E V Tivanova, K F Khafizov, V G Akimki. [Monitoring the spread of the SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbecovirus) variants in the Moscow region using targeted high-throughput sequencing]. Voprosy virusologii. vol 66. issue 4. 2021-10-04. PMID:34545719. |
particularly, since the end of 2020, several variants of concern have been identified around the world, including alpha (b.1.1.7), beta (b.1.351), gamma (p.1), and delta (b.1.617.2). |
2021-10-04 |
2023-08-13 |
Not clear |
| Rui Yin, Johnathan D Guest, Ghazaleh Taherzadeh, Ragul Gowthaman, Ipsa Mittra, Jane Quackenbush, Brian G Pierc. Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants. PLoS computational biology. vol 17. issue 9. 2021-10-01. PMID:34491988. |
this is underscored by the emergence and spread of sars-cov-2 variants, including alpha (b.1.1.7) and delta (b.1.617.2), some of which appear to be less effectively targeted by current monoclonal antibodies and vaccines. |
2021-10-01 |
2023-08-13 |
Not clear |
| Christoph J Hemmer, M Löbermann, E C Reisinge. [COVID-19: epidemiology and mutations : An update]. Der Radiologe. vol 61. issue 10. 2021-10-01. PMID:34542699. |
it is 50% more infectious than the alpha variant, and the protective effect of vaccinations against symptomatic disease can be decreased (biontech: delta variant 88%, alpha variant 93.7%; astrazeneca: delta variant 67%, alpha variant 74.5%). |
2021-10-01 |
2023-08-13 |
Not clear |
| Sabrina Jungnick, Bernhard Hobmaier, Lena Mautner, Mona Hoyos, Maren Haase, Armin Baiker, Heidi Lahne, Ute Eberle, Clara Wimmer, Sabrina Hepner, Annika Sprenger, Carola Berger, Alexandra Dangel, Siegfried Ippisch, Sonja Hahner, Manfred Wildner, Bernhard Liebl, Nikolaus Ackermann, Andreas Sing, Volker Fingerl. In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta). Microorganisms. vol 9. issue 9. 2021-10-01. PMID:34576862. |
in vitro rapid antigen test performance with the sars-cov-2 variants of concern b.1.1.7 (alpha), b.1.351 (beta), p.1 (gamma), and b.1.617.2 (delta). |
2021-10-01 |
2023-08-13 |
human |
| Sabrina Jungnick, Bernhard Hobmaier, Lena Mautner, Mona Hoyos, Maren Haase, Armin Baiker, Heidi Lahne, Ute Eberle, Clara Wimmer, Sabrina Hepner, Annika Sprenger, Carola Berger, Alexandra Dangel, Siegfried Ippisch, Sonja Hahner, Manfred Wildner, Bernhard Liebl, Nikolaus Ackermann, Andreas Sing, Volker Fingerl. In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta). Microorganisms. vol 9. issue 9. 2021-10-01. PMID:34576862. |
in this study, four rats for nasal swab testing were investigated using cultured strains of b.1.1 (non-voc), b.1.1.7 (alpha), b.1.351 (beta), p.1 (gamma), and b.1.617.2 (delta). |
2021-10-01 |
2023-08-13 |
human |
| G Gemma Stathatos, Jessica E M Dunleavy, Jennifer Zenker, Moira K O'Brya. Delta and epsilon tubulin in mammalian development. Trends in cell biology. vol 31. issue 9. 2021-09-30. PMID:33867233. |
delta (δ-) and epsilon (ε-) tubulin are lesser-known cousins of alpha (α-) and beta (β-) tubulin. |
2021-09-30 |
2023-08-13 |
Not clear |
| Parham Jalali, Nasrin Sho'our. Neurofeedback Training Protocol Based on Selecting Distinctive Features to Treat or Reduce ADHD Symptoms. Clinical EEG and neuroscience. vol 52. issue 6. 2021-09-30. PMID:34338564. |
likewise, inhibiting alpha band activity and enhancing delta one in f7 or t5 channels was proposed as a new nfb treatment protocol for adhd. |
2021-09-30 |
2023-08-13 |
Not clear |
| Byung Uk Le. Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds. International journal of environmental research and public health. vol 18. issue 18. 2021-09-30. PMID:34574724. |
sars-cov-2 and its variants such as the alpha voc and delta voc satisfy the four fundamental conditions. |
2021-09-30 |
2023-08-13 |
human |
| Miloš Ajčević, Giovanni Furlanis, Marcello Naccarato, Aleksandar Miladinović, Alex Buoite Stella, Paola Caruso, Tommaso Cillotto, Agostino Accardo, Paolo Manganott. Hyper-acute EEG alterations predict functional and morphological outcomes in thrombolysis-treated ischemic stroke: a wireless EEG study. Medical & biological engineering & computing. vol 59. issue 1. 2021-09-29. PMID:33274407. |
relative delta power and alpha power, delta/alpha (dar), and (delta+theta)/(alpha+beta) (dtabr) ratios significantly correlated with nihss 7-day (rho = 0.80, - 0.81, 0.76, 0.75, respectively) and nihss 12-month (0.73, - 0.78, 0.74, 0.73, respectively), as well as with final infarct volume (0.75, - 0.70, 0.78, 0.62, respectively). |
2021-09-29 |
2023-08-13 |
Not clear |
| Hengcong Liu, Juanjuan Zhang, Jun Cai, Xiaowei Deng, Cheng Peng, Xinghui Chen, Juan Yang, Qianhui Wu, Zhiyuan Chen, Wen Zheng, Cécile Viboud, Wenhong Zhang, Marco Ajelli, Hongjie Y. Herd immunity induced by COVID-19 vaccination programs to suppress epidemics caused by SARS-CoV-2 wild type and variants in China. medRxiv : the preprint server for health sciences. 2021-09-29. PMID:34341803. |
herd immunity for new variants, such as alpha or delta, can only be achieved with more efficacious vaccines and coverages above 80-90%. |
2021-09-29 |
2023-08-13 |
Not clear |
| Katherine A Twohig, Tommy Nyberg, Asad Zaidi, Simon Thelwall, Mary A Sinnathamby, Shirin Aliabadi, Shaun R Seaman, Ross J Harris, Russell Hope, Jamie Lopez-Bernal, Eileen Gallagher, Andre Charlett, Daniela De Angelis, Anne M Presanis, Gavin Dabrer. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. The Lancet. Infectious diseases. 2021-09-28. PMID:34461056. |
hospital admission and emergency care attendance risk for sars-cov-2 delta (b.1.617.2) compared with alpha (b.1.1.7) variants of concern: a cohort study. |
2021-09-28 |
2023-08-13 |
Not clear |
| Katherine A Twohig, Tommy Nyberg, Asad Zaidi, Simon Thelwall, Mary A Sinnathamby, Shirin Aliabadi, Shaun R Seaman, Ross J Harris, Russell Hope, Jamie Lopez-Bernal, Eileen Gallagher, Andre Charlett, Daniela De Angelis, Anne M Presanis, Gavin Dabrer. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. The Lancet. Infectious diseases. 2021-09-28. PMID:34461056. |
it is suspected that the delta variant is associated with more severe disease than the previously dominant alpha (b.1.1.7) variant. |
2021-09-28 |
2023-08-13 |
Not clear |
| Katherine A Twohig, Tommy Nyberg, Asad Zaidi, Simon Thelwall, Mary A Sinnathamby, Shirin Aliabadi, Shaun R Seaman, Ross J Harris, Russell Hope, Jamie Lopez-Bernal, Eileen Gallagher, Andre Charlett, Daniela De Angelis, Anne M Presanis, Gavin Dabrer. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. The Lancet. Infectious diseases. 2021-09-28. PMID:34461056. |
we aimed to characterise the severity of the delta variant compared with the alpha variant by determining the relative risk of hospital attendance outcomes. |
2021-09-28 |
2023-08-13 |
Not clear |
| Jerard Seghatchia. Spotlight on the latest trends on CoV-2 Alpha and Delta variants in the UK; Targeting blood donor population for assessing the effect of the mRNA vaccines on the seroprevalence of CoV-2 Delta variant antibodies and reflections on the management of alloimmunisation in transfused patients with constitutional anaemias in Norway. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. vol 60. issue 5. 2021-09-27. PMID:34483033. |
spotlight on the latest trends on cov-2 alpha and delta variants in the uk; targeting blood donor population for assessing the effect of the mrna vaccines on the seroprevalence of cov-2 delta variant antibodies and reflections on the management of alloimmunisation in transfused patients with constitutional anaemias in norway. |
2021-09-27 |
2023-08-13 |
Not clear |
| Xanthi Stachtea, Ioanna Zioga, Anastasios E Giannopoulos, Panos C Papageorgiou, Sotirios T Spantideas, Nikolaos C Kapsalis, Christos N Capsalis, Charalabos C Papageorgio. Test-retest reliability of brain oscillations in a prepulse inhibition and facilitation paradigm: effects of gender in healthy humans. Neuroreport. vol 31. issue 13. 2021-09-24. PMID:32694313. |
the results showed good-to-excellent reproducibility of eeg power (both in ppi and ppf) over all frequency bands (iccs > 0.75), except for delta (iccs < 0.75), with alpha exhibiting the highest repeatability performance. |
2021-09-24 |
2023-08-13 |
human |
| Yamin Li, Wen Shi, Zhian Liu, Jing Li, Qiang Wang, Xiangguo Yan, Zehong Cao, Gang Wan. Effective Brain State Estimation During Propofol-Induced Sedation Using Advanced EEG Microstate Spectral Analysis. IEEE journal of biomedical and health informatics. vol 25. issue 4. 2021-09-24. PMID:32749987. |
the process of transition from the awake baseline to moderate sedation was accompanied by apparent increases in microstate (a, b, and f) energy, especially in the whole-brain delta band, frontal alpha band and beta band. |
2021-09-24 |
2023-08-13 |
Not clear |
| Amarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, Sijy O'Dell, Chloe A Talana, Lilin Lai, Jim Albert, Evan Anderson, Hamilton Bennett, Kizzmekia S Corbett, Britta Flach, Lisa Jackson, Brett Leav, Julie E Ledgerwood, Catherine J Luke, Mat Makowski, Martha C Nason, Paul C Roberts, Mario Roederer, Paulina A Rebolledo, Christina A Rostad, Nadine G Rouphael, Wei Shi, Lingshu Wang, Alicia T Widge, Eun Sung Yang, John H Beigel, Barney S Graham, John R Mascola, Mehul S Suthar, Adrian B McDermott, Nicole A Doria-Rose, Jae Arega, John H Beigel, Wendy Buchanan, Mohammed Elsafy, Binh Hoang, Rebecca Lampley, Aparna Kolhekar, Hyung Koo, Catherine Luke, Mamodikoe Makhene, Seema Nayak, Rhonda Pikaart-Tautges, Paul C Roberts, Janie Russell, Elisa Sindall, Jim Albert, Pratap Kunwar, Mat Makowski, Evan J Anderson, Amer Bechnak, Mary Bower, Andres F Camacho-Gonzalez, Matthew Collins, Ana Drobeniuc, Venkata Viswanadh Edara, Srilatha Edupuganti, Katharine Floyd, Theda Gibson, Cassie M Grimsley Ackerley, Brandi Johnson, Satoshi Kamidani, Carol Kao, Colleen Kelley, Lilin Lai, Hollie Macenczak, Michele Paine McCullough, Etza Peters, Varun K Phadke, Paulina A Rebolledo, Christina A Rostad, Nadine Rouphael, Erin Scherer, Amy Sherman, Kathy Stephens, Mehul S Suthar, Mehgan Teherani, Jessica Traenkner, Juton Winston, Inci Yildirim, Lee Barr, Joyce Benoit, Barbara Carste, Joe Choe, Maya Dunstan, Roxanne Erolin, Jana Ffitch, Colin Fields, Lisa A Jackson, Erika Kiniry, Susan Lasicka, Stella Lee, Matthew Nguyen, Stephanie Pimienta, Janice Suyehira, Michael Witte, Hamilton Bennett, Nedim Emil Altaras, Andrea Carfi, Marjorie Hurley, Brett Leav, Rolando Pajon, Wellington Sun, Tal Zaks, Rhea N Coler, Sasha E Larsen, Kathleen M Neuzil, Lisa C Lindesmith, David R Martinez, Jennifer Munt, Michael Mallory, Caitlin Edwards, Ralph S Baric, Nina M Berkowitz, Eli A Boritz, Kevin Carlton, Kizzmekia S Corbett, Pamela Costner, Adrian Creanga, Nicole A Doria-Rose, Daniel C Douek, Britta Flach, Martin Gaudinski, Ingelise Gordon, Barney S Graham, LaSonji Holman, Julie E Ledgerwood, Kwanyee Leung, Bob C Lin, Mark K Louder, John R Mascola, Adrian B McDermott, Kaitlyn M Morabito, Laura Novik, Sarah O'Connell, Sijy O'Dell, Marcelino Padilla, Amarendra Pegu, Stephen D Schmidt, Wei Shi, Phillip A Swanson, Chloe A Talana, Lingshu Wang, Alicia T Widge, Eun Sung Yang, Yi Zhang, James D Chappell, Mark R Denison, Tia Hughes, Xiaotao Lu, Andrea J Pruijssers, Laura J Stevens, Christine M Posavad, Michael Gale, Vineet Menachery, Pei-Yong Sh. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science (New York, N.Y.). vol 373. issue 6561. 2021-09-24. PMID:34385356. |
here, we assess the effect of sars-cov-2 variants b.1.1.7 (alpha), b.1.351 (beta), p.1 (gamma), b.1.429 (epsilon), b.1.526 (iota), and b.1.617.2 (delta) on binding, neutralizing, and angiotensin-converting enzyme 2 (ace2)–competing antibodies elicited by the messenger rna (mrna) vaccine mrna-1273 over 7 months. |
2021-09-24 |
2023-11-08 |
human |